887 Great Northern Way
BC V5T 4T5
Canada - Map
QLT Inc., a biotechnology company, engages in the development and commercialization of ocular products that address the unmet medical needs of patients and clinicians worldwide. The company focuses on the development of QLT091001, a synthetic retinoid compound, which has been completed Phase Ib retreatment clinical trials for the treatment of leber congenital amaurosis and retinitis pigmentosa; Phase Ib clinical trials for the treatment of Retinitis Pigmentosa with autosomal dominant mutation in RPE65; and Phase IIa clinical trials for the treatment of impaired dark adaptation. QLT Inc. was founded in 1981 and is headquartered in Vancouver, Canada.
|Dr. Geoffrey F. Cox Ph.D., BSc,
Interim Chief Exec. Officer and Director
|Mr. William Glen Ibbott ,
Chief Financial Officer and Sr. VP of Fin.
|Dr. Lana Elizabeth Elizabeth Janes ,
Chief Patent Officer and Sr. VP of Intellectual Property & Technology Devel.
|Ms. Dori C. Assaly ,
Sr. VP of Legal and Corp. Sec.
|Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|